IMPACT OF POOR PERSISTENCE AND ADHERENCE

Despite the development of great therapeutic interventions many patients still do not thrive or achieve optimal results on their treatment.  The reason for these poor patient outcomes can vary from lack of education about the disease or treatment to the inability to afford medicine, or lack of adherence to their therapy.  According to the WHO only 50% of the patients with chronic conditions take their medication as prescribed,  For Pharmaceutical companies this translates roughly into ONE RAND in lost revenue for every SALES rand realized.


POOR ADHERENCE


  • Decreased Drug Efficacy

    The patient loses as poor adherence limits effective management and control of chronic illnesses.

  • Poor Outcome

    The doctor loses credibility with the patient as his health deteriorates

  • Increased Care Costs

    Medical Aid & Payer loses at the patient does not recover

  • Lost Sales

    Pharmaceutical Industry loses because of lost sales due to early dropout


+ PHARMACALL =


capsules-pharmacall

ROBUST ADHERENCE


  • Increased Drug Efficacy

    The patient wins as robust adherence effectively manages and controls chronic illnesses.

  • Improved Outcome

    The Doctor gains credibility as the patients health improves

  • Decreased Care Costs

    Medical Aid & Payer wins as the patient recovers and expenses drop

  • Retained Sales

    Pharmaceutical Industry wins as sales are retained due to late or no dropout


By bridging the gap “beyond the prescription” we are able to ensure that all role players benefit, from the Patient to the Doctor to Funder and Manufacturer


Bringing together 12 years of

[/ult_animation_block]

EXPERIENCE, KNOWLEDGE and TECHNOLOGY

to provide affordable patient compliance solutions for the Pharmaceutical industry

SUCCESS BEYOND the PRESCRIPTION